GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neximmune NEXI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 28 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2023

Net income

−$32.3m

FY2018FY2023

Free cash flow

−$31.5m

FY2018FY2023

Shareholders' equity

$3.5m

FY2018FY2023

Income statement

Fiscal years

FY2023FY2022FY2022FY2021FY2020FY2019FY2018
Gross profit−$1.0m—−$1.5m−$870,285−$618,990−$436,365−$204,646
Research and development$18.3m$46.8m$47.1m$37.5m$17.8m$15.2m$8.0m
Operating income−$29.2m−$63.1m−$63.1m−$53.3m−$27.9m−$20.9m−$13.2m
Net income−$32.3m−$62.5m$514.2m−$51.7m−$31.6m−$20.3m−$12.8m
Diluted earnings per share-30.33-65.11530.41-56.66-32.01-31.41-9.30

Balance sheet

At each fiscal year end

FY2023FY2022FY2022FY2021FY2020FY2019FY2018
Total assets$8.6m$43.1m$43.1m$91.0m$11.3m$13.7m$14.1m
Cash and short-term investments$4.6m$34.6m$34.6m$81.8m$5.1m$10.1m$12.1m
Total liabilities$5.1m$10.8m$10.8m$7.3m$27.1m$3.1m$3.3m
Debt$68,809$1.0m$1.0m—$19.1m$53.6m$35.0m
Shareholders' equity$3.5m$32.3m$32.3m$83.8m−$15.8m$10.6m$10.8m
Shares outstanding1m1m1m1m1m1m1m

Cash flow

Fiscal years

FY2023FY2022FY2022FY2021FY2020FY2019FY2018
Cash from operations−$31.4m−$51.2m−$51.2m−$45.8m−$26.4m−$19.4m−$11.1m
Capital spending−$48,720−$1.3m−$1.3m−$2.4m−$864,659−$1.2m−$937,768
Free cash flow−$31.5m−$52.4m−$52.4m−$48.1m−$27.3m−$20.7m−$12.1m
Dividends paid———−$377,562———

Latest quarters

By quarter end

Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022
Operating income−$2.7m−$2.8m−$4.7m−$10.0m−$7.8m−$9.8m−$17.3m−$14.9m
Net income−$2.3m−$3.1m−$5.4m−$9.9m−$7.6m−$9.6m−$16.9m−$14.7m
Diluted earnings per share-1.69-2.46-5.04-9.40-7.27-9.20-16.24-15.03
Cash from operations−$2.0m−$2.0m−$5.0m−$7.0m−$6.0m−$12.0m−$11.0m−$11.0m
Total assets$5.9m$9.0m$8.6m$14.6m$23.5m$30.7m$43.1m$57.7m
Cash and short-term investments$2.4m$4.5m—$9.0m$16.3m$22.3m$34.6m$45.9m
Debt—$68,809—$501,811$545,285$587,944$599,047$594,664
Shareholders' equity$920,539$3.0m$3.5m$8.3m$17.0m$23.6m$32.3m$47.7m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income44.5%——
Net income39.1%——

Valuation history

At each fiscal year end

FY2023FY2021
Price to earnings-0.0-0.2

Share price return

Finished calendar years

20252024202320222021
Return-100%-85%-63%-94%-81%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 25-to-1 reverse split · 19 Oct 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.